SI-BONE, Inc.

NASDAQ:SIBN

Medical - Devices

Healthcare
$23.54 +3.45%

+$0.53 today

Market cap
$1.06B
Beta
0.70
P/E (TTM)
-41.4
EPS (TTM)
-$0.38
52W Low $11.48High $21.89

Volume 1.12M

Average 0.68M

SIBN Interest Income

Income earned on cash, deposits, and investments held by the company.

SI-BONE, Inc.NASDAQ: SIBN

Interest Income · Q1 FY2026 · quarter ended Mar 2026

Interest income declines year over year

Q1 FY2026 interest income of $1.35M fell 15.2% year over year, ahead of the -20.4% change in trailing-twelve-month interest income. Sequentially, it fell 6.6% from the prior quarter. Over 3 fiscal years it compounded at +67.0% a year.

Context

  • Interest income amounted to 3.0% of revenue in FY2025, down 1.7 pp from a year earlier.
  • Interest income increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -15.2% holds above the trailing-twelve-month pace of -20.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.35M-6.6% QoQ
Last fiscal yearDec 2025
$6.07M-22.6% YoY
LTMMar 2026
$5.83M-20.4% YoY
Interest Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-15.2%——
1 year-22.6%——
3-year CAGR+67.0%——
5-year CAGR——
10-year CAGR——

Interest Income history

USD · from the income statement

Latest · FY2025
6.07M USD
Year-over-year change
-22.6%
4-year CAGR
+139.0%

Interest Income vs competitors

How SIBN compares with its peers on the latest reported figures

  • SIBN's LTM Mar 2026 interest income of $5.83M is the 4th highest of the 6 companies compared; the peer median is $10.2M.
  • Its year-over-year change of -20.4% is the 3rd highest of 4, against a peer median of +16.9%.
  • Interest income amounts to 2.8% of revenue for SIBN, versus a peer median of 0.1%.
SIBN Competitors Peer median
Interest Income for SIBN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SNNSmith & Nephew plcFY2025$28.07M +16.9%+26.1%0.5%
SYKStryker CorporationLTM Jun 2026$28M -79.9%+8.8%0.1%
GMEDGlobus Medical, Inc.LTM Jun 2026$10.2M +329.7%-20.5%0.3%
SIBNSI-BONE, Inc.LTM Mar 2026$5.83M -20.4%+67.0%2.8%
CNMDCONMED CorporationLTM Mar 2026$0 ——0.0%
ATECAlphatec Holdings, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding SIBN) $10.2M+16.9%+8.8%0.1%

Competitors are the stored peer set for SIBN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue90.15M106.41M138.89M167.18M200.93M
Cost of Revenue10.43M15.71M29.47M35.06M41.05M
Gross Profit79.72M90.7M109.42M132.12M159.88M
Gross Margin88.4%85.2%78.8%79.0%79.6%
Research & Development12.44M13.63M15.03M16.56M17.45M
Selling, General & Admin118.95M136.69M141.32M150.81M164.76M
Operating Expenses131.39M150.31M156.35M167.37M182.21M
Depreciation & Amortization2.09M3.45M5.43M4.38M2.72M
EBITDA(50.97M)(54.99M)(34.45M)(23.09M)(10.91M)
EBITDA Margin-56.5%-51.7%-24.8%-13.8%-5.4%
Operating Income(51.67M)(59.61M)(46.93M)(35.25M)(22.33M)
Operating Margin-57.3%-56.0%-33.8%-21.1%-11.1%
Interest Income186K1.3M6.92M7.85M6.07M
Interest Expense5.37M2.82M3.46M3.44M5.28M
Other Income / Expenses(4.9M)(1.65M)3.6M4.34M3.42M
Income Before Tax(56.57M)(61.26M)(43.34M)(30.91M)(18.91M)
Pre-Tax Margin-62.8%-57.6%-31.2%-18.5%-9.4%
Income Tax Expense00000
Net Income(56.57M)(61.26M)(43.34M)(30.91M)(18.91M)
Net Margin-62.8%-57.6%-31.2%-18.5%-9.4%
EPS (Basic)(1.71)(1.79)(1.13)(0.75)(0.44)
EPS (Diluted)(1.71)(1.79)(1.13)(0.75)(0.44)
Weighted Avg Shares33.15M34.2M38.43M41.47M43.51M
Weighted Avg Shares (Diluted)33.15M34.2M38.43M41.47M43.51M

SI-BONE, Inc.

NASDAQ:SIBN

Intrinsic Alpha fair value

Locked

Current Price

$23.54

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.